Thomas Hankemeier is full professor of Analytical BioSciences at the LACDR, Leiden University. He leads as principal investigator the Analytical BioSciences and Metabolomics group, and he is the chair of the new Division of Systems Biomedicine and Pharmacology.
His research is aiming at innovative analytical tools for metabolomics-driven systems biology in personalised health strategies.
Luojiao Huang, Nicolas Drouin, Jason Causon, Agnieszka Wegrzyn, Jose Castro-Perez, Ronan Fleming, Amy Harms, Thomas Hankemeier
Analytical Chemistry (volume 95, issue 6)
Naama Karu, Alida Kindt, Adriaan J van Gammeren, Anton A M Ermens, Amy C Harms, Lutzen Portengen, Roel C H Vermeulen, Willem A Dik, Anton W Langerak, Vincent H J van der Velden, Thomas Hankemeier
Metabolites (volume 12, issue 7)
Naama Karu, Alida Kindt, Lieke Lamont, Adriaan J van Gammeren, Anton A M Ermens, Amy C Harms, Lutzen Portengen, Roel C H Vermeulen, Willem A Dik, Anton W Langerak, Vincent H J van der Velden, Thomas Hankemeier
Metabolites (volume 12, issue 7)
hankemeijer@lacdr.leidenuniv.nl
Leiden University
Gorlaeus Building
Einsteinweg 55
2333 CC Leiden
Room number GW4.07
The environment we live in has a dominant impact on our health. It explains an estimated seventy percent of the chronic disease burden. Where we live, what we eat, how much we exercise, the air we breathe and whom we associate with; all of these environmental factors play a role. The combination of these factors over the life course is called the exposome. There is general (scientific) consensus that understanding more about the exposome will help explain the current burden of disease and that it provides entry points for prevention and ...
Read More
